share_log

This AI Stock Surges Nearly 3% Premarket As SoftBank Reportedly Plans To Launch AI-Powered Medical Service In Japan

This AI Stock Surges Nearly 3% Premarket As SoftBank Reportedly Plans To Launch AI-Powered Medical Service In Japan

隨着軟銀計劃在日本推出人工智能醫療服務,這家人工智能股票在盤前漲近3%
Benzinga ·  06/26 18:42

SoftBank Group (OTC:SFTBY) (OTC:SFTBF) is set to introduce a medical service in Japan that uses artificial intelligence to analyze personal medical data, including genetic information. The service will be launched through a joint venture with U.S. healthcare company Tempus AI Inc. (NASDAQ:TEM). Following the report, Tempus AI Inc.'s stock surged nearly 3% in pre-market hours trading.

SoftBank Group (場外交易:SFTBY) (場外交易:SFTBF)將會在日本推出一項醫療服務,該服務使用人工智能分析個人醫療數據,包括基因信息。該服務將通過與美國醫療保健公司Tempus AI Inc.(納斯達克:TEM)的合資企業的聯合推出。據Nikkei週二報道,該服務預計將於7月份開始營運,計劃在一至兩年內開始提供服務。此消息發佈後,Tempus AI股價在盤前交易中上漲了近3%。

What Happened: The joint venture, capitalized at 30 billion yen ($188 million), will be equally owned by SoftBank Group and Tempus AI. The venture is expected to commence operations as early as July and aims to start providing services within one to two years, reported Nikkei on Tuesday.

發生了什麼: 這家總資本爲300億日元(1.88億美元)的合資企業將由SoftBank Group和Tempus AI平分股權。據《Nikkei》週二報道,合資企業預計將於7月份開始運作,並計劃在一至兩年內開始提供服務。

Tempus AI, through its analytical machine learning platform, enables physicians to make real-time, data-driven decisions to provide personalized care and targeted therapies for patients using the power of AI in healthcare.

通過其分析機器學習平台,Tempus AI可以使醫生作出實時、數據驅動的決策,爲患者提供個性化護理和有針對性的治療,利用人工智能在醫療保健領域的能力。

SoftBank and Tempus AI did not immediately respond to Benzinga's request for comment.

SoftBank和Tempus AI還未對Benzinga的置評請求做出回應。

Why It Matters: This initiative comes at a crucial time for SoftBank, which has faced significant challenges in recent years. In 2019, SoftBank's Vision Fund sold all of its shares in Nvidia, missing out on a potential gain of over $150 billion.

爲什麼它很重要: 此舉對SoftBank來說是在一個關鍵時刻,該公司在最近幾年面臨了重大挑戰。2019年,SoftBank的Vision Fund出售了其在英偉達的所有股票,錯失了逾1500億美元的潛在收益。

Moreover, Masayoshi Son has seen a notable drop in shareholder support for his reappointment as CEO, falling from 95.93% to 79.22% in a year, following a recommendation by proxy advisor Institutional Shareholder Services.

此外,孫正義在股東支持其連任CEO方面出現了明顯下降,經過股權代理機構Institutional Shareholder Services的建議,支持度從95.93%下降到79.22%。

In addition, activist investor Elliott Investment Management has taken a $2 billion stake in SoftBank and is demanding a $15 billion share buyback, reflecting investor concerns over the company's strategic direction.

此外,激進投資者Elliott Investment Management已經獲得了價值20億美元的SoftBank股份,並要求進行150億美元的股票回購,反映了投資者對該公司戰略方向的擔憂。

Finally, the collaboration between SoftBank and Tempus AI aligns with a broader trend of integrating AI into healthcare. For instance, Microsoft-backed OpenAI has partnered with Color Health to develop AI-driven cancer care solutions.

最後,SoftBank與Tempus AI之間的合作符合將人工智能與醫療保健業務整合的趨勢。例如Microsoft支持的OpenAI已經與Color Health合作開發了基於人工智能的癌症治療解決方案。Microsoft-b價格走勢: Tempus AI Inc.週二收盤價爲24.96美元,當日下跌了1.38%。在盤前交易中,該股上漲了2.52%。根據Benzinga Pro的數據,自公開上市以來,Tempus AI Inc.的股價已經下跌了37.99%。

Price Action: Tempus AI Inc. closed at $24.96 on Tuesday, experiencing a decrease of 1.38% for the day. In pre-market trading, the stock rose by 2.52%. Since its public debut, Tempus AI Inc. has seen a decline of 37.99%, according to data from Benzinga Pro.

價格行動:Tempus AI公司週二收盤價爲24.96美元,當天下跌1.38%。在美股盤前交易中,該股票上漲了2.52%。根據Benzinga Pro的數據,Tempus AI公司自上市以來已經下跌了37.99%。

Image Via Shutterstock

圖片來自Shutterstock。

This story was generated using Benzinga Neuro and edited by Kaustubh Bagalkote

本報道使用Benzinga Neuro生成,並由Kaustubh Bagalkote

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論